Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, China.
Int J Mol Sci. 2018 Jan 21;19(1):313. doi: 10.3390/ijms19010313.
G protein-coupled receptors (GPCRs) have a substantial role in tumorigenesis and are described as a "cancer driver". Aberrant expression or activation of GPCRs leads to the deregulation of downstream signaling pathways, thereby promoting cancer progression. In hepatocellular carcinoma (HCC), the Wnt signaling pathway is frequently activated and it is associated with an aggressive HCC phenotype. Frizzled (FZD) receptors, a family member of GPCRs, are known to mediate Wnt signaling. Accumulating findings have revealed the deregulation of FZD receptors in HCC and their functional roles have been implicated in HCC progression. Given the important role of FZD receptors in HCC, we summarize here the expression pattern of FZD receptors in HCC and their corresponding functional roles during HCC progression. We also further review and highlight the potential targeting of FZD receptors as an alternative therapeutic strategy in HCC.
G 蛋白偶联受体(GPCRs)在肿瘤发生中具有重要作用,被描述为“癌症驱动因素”。GPCRs 的异常表达或激活导致下游信号通路失调,从而促进癌症进展。在肝细胞癌(HCC)中,Wnt 信号通路经常被激活,并且与侵袭性 HCC 表型相关。Frizzled(FZD)受体是 GPCRs 的一个家族成员,已知其介导 Wnt 信号。越来越多的研究结果表明,FZD 受体在 HCC 中失调,并且它们的功能作用与 HCC 进展有关。鉴于 FZD 受体在 HCC 中的重要作用,我们在此总结了 FZD 受体在 HCC 中的表达模式及其在 HCC 进展过程中的相应功能作用。我们还进一步回顾和强调了作为 HCC 治疗策略的替代方案,靶向 FZD 受体的潜在可能性。